Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

Clinical trial NCT07447050 · RECRUITING

Trial details

NCT number: NCT07447050
Sponsor: University of California, Irvine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Sarcoma Gastric (Stomach) Cancer Lung Cancer Head and Neck Cancer Colorectal Cancer Ovarian Cancer Liver Cancer Genitourinary Cancer Gynecologic Cancer

Start date: 2025-12-23
Primary completion: 2027-12-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.